Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank Central Asia Tbk (BBCA) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Bank Central Asia TbkTrade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Bank Central Asia Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bank Central Asia Tbk trades at Rp6,225 (market cap 753.61T, 180.06M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 310.75B, 159.2K 24h volume). The key difference: Bank Central Asia Tbk is far larger — about 2425.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Bank Central Asia Tbk is more actively traded (180.06M versus 159.2K). Which is the better fit depends on your goals.

BBCADGNS
Market Cap
753.61T310.75B
Volume
180.06M159.2K
Lot
1.8M1.59K
Turnover
1.11T34.72M
Average Price
6,176.89218.06
Value
1.11T34.72M
Indicative Equilibrium Price
6,225220
Indicative Equilibrium Volume
292.85K6

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BBCA
View details
DGNS
View details

About Bank Central Asia Tbk

PT. Bank Central Asia, Tbk (the Company) was established under the name of N.V. Perseroan Dagang Dan Industrie Semarang Knitting Factory based on notarial deed No. 38 of Raden Mas Soeprapto dated 10 August 1955, which was then changed to PT Bank Central Asia based on notarial deed No. 144 of Ridwan Suselo dated 21 May 1974.

Read more on BBCA

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS